Related Experiment Video
Updated: Sep 10, 2025
07:22
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
554
A Unique Dermatologic Adverse Event from Enfortumab Vedotin
Megan Bielawa1, Apoorva Trivedi2
1Memorial Sloan Kettering Dermatology Service, 800 Veterans Memorial Highway 2 Floor, Hauppauge NY 11788.
Journal of Dermatology for Physician Assistants : Official Journal of the Society of Dermatology Physician Assistants
|August 25, 2025
Summary
Enfortumab vedotin (EV) can cause rare but significant skin reactions like blistering. Early recognition and management of these dermatologic toxicities are vital for continuing cancer treatment.
Area of Science:
- Oncology
- Dermatology
Background:
- Enfortumab vedotin (EV) is a chemotherapy for metastatic urothelial cancer.
- Rashes are common EV side effects, but literature on bullous dermatoses is limited.
Purpose of the Study:
- To report a unique case of bullous dermatosis associated with EV therapy.
- To review diagnostic workup and management strategies for EV-induced skin toxicities.
Main Methods:
- Case report detailing a patient's experience with EV.
- Review of diagnostic procedures and treatment interventions for bullous dermatosis.
Main Results:
- A unique bullous dermatosis presentation in a patient receiving EV was observed.
- The case highlights the importance of recognizing and managing EV-related cutaneous adverse events.
Conclusions:
- Dermatologic toxicities, including bullous reactions, can occur with enfortumab vedotin.
- Prompt identification and management of these adverse events are crucial for patient care and treatment adherence.
More Related Videos
Related Concept Videos
01:27Allergic Drug Reactions
978
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
978
01:19Pharmacovigilance
989
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
989
01:12Local Anesthetics: Adverse Effects
492
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
492